Field | Row 1 |
---|---|
adsh | 0000950170-25-068040 |
cik | 1620463 |
name | ATHIRA PHARMA, INC. |
sic | 2836 |
countryba | US |
stprba | WA |
cityba | BOTHELL |
zipba | 98011 |
bas1 | 18706 NORTH CREEK PARKWAY, SUITE 104 |
bas2 | |
baph | (425) 620-8501 |
countryma | US |
stprma | WA |
cityma | BOTHELL |
zipma | 98011 |
mas1 | 18706 NORTH CREEK PARKWAY, SUITE 104 |
mas2 | |
countryinc | |
stprinc | |
ein | 453368487 |
former | M3 BIOTECHNOLOGY, INC. |
changed | 20140924 |
afs | 4-NON |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250509 |
accepted | 2025-05-09 16:15:00.0 |
prevrpt | 0 |
detail | 1 |
instance | atha-20250331_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0000950170-25-068040 | 20241231 | Cash And Cash Equivalents At Carrying Value | 48438000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2679000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-068040 | 20250331 | Cash And Cash Equivalents At Carrying Value | 26422000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Cash And Cash Equivalents At Carrying Value | 4037000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= U S Government Agencies Debt Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-068040 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 49069000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Common Stock Shares Issued | 39042445.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Earnings Per Share Basic | -0.2300 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Earnings Per Share Diluted | -0.6900 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Gain Loss On Sale Of Property Plant Equipment | -7000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Increase Decrease In Operating Lease Liability | -87000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -5000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-068040 | 20250331 | Other Nonoperating Income Expense | 393000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Payments To Acquire Available For Sale Securities Debt | 5911000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Short Term Investments | 2837000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Stockholders Equity | 4000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20241231 | Stockholders Equity | 4000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20241231 | Stockholders Equity | -406146000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-068040 | 20250331 | Stockholders Equity | 37330000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Accounts Payable Current | 319000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Assets | 58779000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Cash And Cash Equivalents At Carrying Value | 77821000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 91215000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Costs And Expenses | 27687000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Costs And Expenses | 9536000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Earnings Per Share Basic | -0.6900 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Earnings Per Share Diluted | -0.2300 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Liabilities Current | 13135000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Net Cash Provided By Used In Investing Activities | 13041000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Operating Income Loss | -9536000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Prepaid Expense And Other Assets Current | 3183000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Share Based Compensation | 2679000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20231231 | Stockholders Equity | -349000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-068040 | 20241231 | Stockholders Equity | 450982000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-068040 | 20241231 | Other Assets Noncurrent | 55000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1637000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1637000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-068040 | 20250331 | Cash And Cash Equivalents At Carrying Value | 13000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= Money Market Funds; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-068040 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 78452000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Common Stock Shares Authorized | 900000000.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Common Stock Shares Issued | 39040945.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Common Stock Shares Outstanding | 39040945.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Depreciation | 242000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | General And Administrative Expense | 5234000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -1155000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Operating Lease Liability Current | 426000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 57000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 18957000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Stockholders Equity | -335543000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-068040 | 20250331 | Stockholders Equity | -4000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-068040 | 20250331 | Stockholders Equity | 4000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 38321573.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 266000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Accrued Liabilities Current | 12402000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2679000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Assets Current | 54841000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Cash And Cash Equivalents At Carrying Value | 30000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= Money Market Funds; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-068040 | 20241231 | Cash And Cash Equivalents At Carrying Value | 29721000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash Equivalents; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-068040 | 20250331 | Cash And Cash Equivalents At Carrying Value | 20689000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash Equivalents; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-068040 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -3254000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Net Income Loss | -26337000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-068040 | 20240331 | Operating Income Loss | -27687000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Operating Lease Right Of Use Asset | 808000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | 212000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-068040 | 20250331 | Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 2850000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Research And Development Expense | 4302000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Restricted Cash Noncurrent | 631000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Stockholders Equity | 44841000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Stockholders Equity | 452619000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-068040 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 65000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 1000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Assets Current | 39853000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Cash And Cash Equivalents At Carrying Value | 16639000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= Commercial Paper; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-068040 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -12763000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Comprehensive Income Net Of Tax | -26125000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Comprehensive Income Net Of Tax | -9148000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Shares | 1500.0000 | shares | 1 | 0000950170-25-068040 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20241231 | Liabilities | 13938000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Liabilities | 6183000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Net Income Loss | -9143000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-068040 | 20240331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | 212000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Other Nonoperating Income Expense | 1350000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Payments To Acquire Available For Sale Securities Debt | 10201000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Property Plant And Equipment Net | 2444000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Research And Development Expense | 21236000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Restricted Cash Noncurrent | 631000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Retained Earnings Accumulated Deficit | -415289000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Share Based Compensation | 1637000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Shares Outstanding | 38326652.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20241231 | Shares Outstanding | 39040945.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20250331 | Shares Outstanding | 39042445.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20250331 | Short Term Investments | 10248000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Stockholders Equity | 442418000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-068040 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 39042445.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 38321573.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Accrued Liabilities Current | 4199000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Assets | 43513000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 27053000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Common Stock Shares Authorized | 900000000.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Shares | 154049.0000 | shares | 1 | 0000950170-25-068040 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20241231 | Liabilities And Stockholders Equity | 58779000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Net Cash Provided By Used In Operating Activities | -14665000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Prepaid Expense And Other Assets Current | 3566000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20231231 | Stockholders Equity | 130188000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20231231 | Stockholders Equity | 4000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20231231 | Stockholders Equity | -309206000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-068040 | 20241231 | Additional Paid In Capital Common Stock | 450982000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Additional Paid In Capital Common Stock | 452619000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -22016000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Common Stock Value | 4000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Depreciation | 243000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -7655000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -353000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Net Cash Provided By Used In Investing Activities | -7351000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Net Cash Provided By Used In Operating Activities | -25804000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Net Income Loss | -26337000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Operating Lease Liability Current | 414000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Operating Lease Liability Noncurrent | 691000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 65000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Property Plant And Equipment Net | 2201000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Retained Earnings Accumulated Deficit | -406146000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20231231 | Stockholders Equity | 439739000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-068040 | 20240331 | Stockholders Equity | -137000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-068040 | 20250331 | Accounts Payable Current | 867000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -4000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Cash And Cash Equivalents At Carrying Value | 19394000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= Commercial Paper; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-068040 | 20241231 | Cash And Cash Equivalents At Carrying Value | 10297000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= U S Government Agencies Debt Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-068040 | 20250331 | Common Stock Shares Outstanding | 39042445.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Common Stock Value | 4000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | General And Administrative Expense | 6451000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Increase Decrease In Operating Lease Liability | -100000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Liabilities And Stockholders Equity | 43513000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Liabilities Current | 5492000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Net Income Loss | -9143000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Operating Lease Liability Noncurrent | 803000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Operating Lease Right Of Use Asset | 743000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Other Assets Noncurrent | 85000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -5000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Payments To Acquire Property Plant And Equipment | 5000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20240331 | Profit Loss | -26337000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Profit Loss | -9143000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-068040 | 20250331 | Restricted Cash Noncurrent | 631000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20231231 | Shares Outstanding | 38172603.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-068040 | 20240331 | Stockholders Equity | 106742000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-068040 | 20241231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-068040 | 20250331 | Stockholders Equity | -415289000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-068040 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 39042445.0000 | shares | 1 | us-gaap/2024 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent. |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Payments To Acquire Available For Sale Securities Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Debt Securities, Available-for-Sale | Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Shares | 0000950170-25-068040 | 1 | 0 | shares | D | Issuance of Common Stock Upon Vesting of Restricted Stock Units, Shares | Issuance of common stock upon vesting of restricted stock units, shares. | |
Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Costs and Expenses | Total costs of sales and operating expenses for the period. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Disposition of Property Plant Equipment | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. |
Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale | Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0000950170-25-068040 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0000950170-25-068040 | 2 | 4 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Short-term investments | 0 |
0000950170-25-068040 | 2 | 5 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
0000950170-25-068040 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
0000950170-25-068040 | 2 | 7 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
0000950170-25-068040 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
0000950170-25-068040 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use asset | 0 |
0000950170-25-068040 | 2 | 10 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other long-term assets | 0 |
0000950170-25-068040 | 2 | 11 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
0000950170-25-068040 | 2 | 14 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
0000950170-25-068040 | 2 | 15 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued liabilities | 0 |
0000950170-25-068040 | 2 | 16 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current operating lease liability | 0 |
0000950170-25-068040 | 2 | 17 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
0000950170-25-068040 | 2 | 18 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, less current portion | 0 |
0000950170-25-068040 | 2 | 19 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
0000950170-25-068040 | 2 | 21 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.0001 par value; 900,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively; 39,042,445 and 39,040,945 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
0000950170-25-068040 | 2 | 22 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
0000950170-25-068040 | 2 | 23 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive (loss) income | 0 |
0000950170-25-068040 | 2 | 24 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
0000950170-25-068040 | 2 | 25 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
0000950170-25-068040 | 2 | 26 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
0000950170-25-068040 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
0000950170-25-068040 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
0000950170-25-068040 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
0000950170-25-068040 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
0000950170-25-068040 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
0000950170-25-068040 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
0000950170-25-068040 | 4 | 4 | IS | 0 | H | Costs And Expenses | us-gaap/2024 | Total operating expenses | 0 |
0000950170-25-068040 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
0000950170-25-068040 | 4 | 6 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income, net | 0 |
0000950170-25-068040 | 4 | 7 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0000950170-25-068040 | 4 | 8 | IS | 0 | H | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Unrealized (loss) gain on available-for-sale securities | 0 |
0000950170-25-068040 | 4 | 9 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss attributable to common stockholders | 0 |
0000950170-25-068040 | 4 | 10 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share attributable to common stockholders, basic | 0 |
0000950170-25-068040 | 4 | 11 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share attributable to common stockholders, diluted | 0 |
0000950170-25-068040 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average shares used in computing net loss per share attributable to common stockholders, basic | 0 |
0000950170-25-068040 | 4 | 13 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted | 0 |
0000950170-25-068040 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
0000950170-25-068040 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance, shares | 0 |
0000950170-25-068040 | 5 | 11 | EQ | 0 | H | Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Shares | 0000950170-25-068040 | Issuance of common stock upon vesting of restricted stock units, shares | 0 |
0000950170-25-068040 | 5 | 12 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
0000950170-25-068040 | 5 | 13 | EQ | 0 | H | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Unrealized gain on available-for-sale securities | 0 |
0000950170-25-068040 | 5 | 14 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0000950170-25-068040 | 5 | 15 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
0000950170-25-068040 | 5 | 16 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance, shares | 0 |
0000950170-25-068040 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
0000950170-25-068040 | 6 | 4 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
0000950170-25-068040 | 6 | 5 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation expense | 0 |
0000950170-25-068040 | 6 | 6 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | Non-cash lease expense | 0 |
0000950170-25-068040 | 6 | 7 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Amortization of premiums and accretion of discounts on available-for-sale securities, net | 1 |
0000950170-25-068040 | 6 | 8 | CF | 0 | H | Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | Loss on disposal of equipment | 1 |
0000950170-25-068040 | 6 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current and long-term assets, net | 1 |
0000950170-25-068040 | 6 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
0000950170-25-068040 | 6 | 12 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liability | 0 |
0000950170-25-068040 | 6 | 13 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
0000950170-25-068040 | 6 | 15 | CF | 0 | H | Payments To Acquire Available For Sale Securities Debt | us-gaap/2024 | Purchases of available-for-sale securities | 1 |
0000950170-25-068040 | 6 | 16 | CF | 0 | H | Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | us-gaap/2024 | Maturities of available-for-sale securities | 0 |
0000950170-25-068040 | 6 | 17 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
0000950170-25-068040 | 6 | 18 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash (used in) provided by investing activities | 0 |
0000950170-25-068040 | 6 | 19 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net decrease in cash, cash equivalents and restricted cash | 0 |
0000950170-25-068040 | 6 | 20 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents and restricted cash, beginning of period | 0 |
0000950170-25-068040 | 6 | 21 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents and restricted cash, end of period | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |